Tannic acid modulates NFκB signaling pathway and skin inflammation in NC/Nga mice through PPARγ expression

Cytokine

Volumn 76, Issue 2, 2015, Pages 206-213

  Karuppagounder, Vengadeshprabhu ^a   Arumugam, Somasundaram ^a   Thandavarayan, Rajarajan Amirthalingam ^a,b   Pitchaimani, Vigneshwaran ^a   Sreedhar, Remya ^a   Afrin, Rejina ^a   Harima, Meilei ^a   Suzuki, Hiroshi ^a   Nomoto, Mayumi ^a   Miyashita, Shizuka ^a   Suzuki, Kenji ^c   Nakamura, Masahiko ^d   Ueno, Kazuyuki ^a   Watanabe, Kenichi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^d Yamanashi Prefectural Central Hospital   (Japan)

Author keywords

Cytokine; Nuclear factor kappa B; Peroxisome proliferator activated receptor; Tannic acid; Tumor necrosis factor

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYCLOOXYGENASE 2; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TANNIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; TANNIN DERIVATIVE;

ACANTHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DOWN REGULATION; HYPERKERATOSIS; INFLAMMATORY CELL; MAST CELL; MOUSE; NONHUMAN; PARAKERATOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; DERMATITIS, ATOPIC; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SKIN;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HMGB1 PROTEIN; INTERFERON-GAMMA; INTERLEUKIN-4; MAST CELLS; MICE; NF-KAPPA B; PPAR GAMMA; SIGNAL TRANSDUCTION; SKIN; TANNINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84943665175     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.05.016     Document Type: Article

References (42)

1. Won T.J., Kim B., Lim Y.T., Song D.S., Park S.Y., Park E.S., et al. Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC/Nga mice. J Appl Microbiol 2011, 110:1195-1202.
2. Kim H., Kim J.R., Kang H., Choi J., Yang H., Lee P., et al. 7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice. PLoS ONE 2014, 9:e104938.
3. Yang G., Choi C.H., Lee K., Lee M., Ham I., Choi H.Y. Effects of Catalpa ovata stem bark on atopic dermatitis-like skin lesions in NC/Nga mice. J Ethnopharmacol 2013, 145:416-423.
4. Chen G., Li J., Ochani M., Rendon-Mitchell B., Qiang X., Susarla S., et al. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J Leukoc Biol 2004, 76:994-1001.
5. Ha T., Xia Y., Liu X., Lu C., Liu L., Kelley J., et al. Glucan phosphate attenuates myocardial HMGB1 translocation in severe sepsis through inhibiting NF-kappaB activation. Am J Physiol Heart Circ Physiol 2011, 301:H848-H855.
6. Yoon J.H., Baek S.J. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J 2005, 46:585-596.
7. Chiba T., Takeuchi S., Esaki H., Yamamura K., Kurihara Y., Moroi Y., et al. Topical application of PPARalpha (but not beta/delta or gamma) suppresses atopic dermatitis in NC/Nga mice. Allergy 2012, 67:936-942.
8. Mao-Qiang M., Fowler A.J., Schmuth M., Lau P., Chang S., Brown B.E., et al. Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. J Invest Dermatol 2004, 123:305-312.
9. Lee J.K., Ha H., Lee H.Y., Park S.J., Jeong S.L., Choi Y.J., et al. Inhibitory effects of heartwood extracts of Broussonetia kazinoki Sieb on the development of atopic dermatitis in NC/Nga mice. Biosci Biotechnol Biochem 2010, 74:1802-1806.
10. Kim M.J., Choung S.Y. Mixture of polyphenols and anthocyanins from vaccinium uliginosum L. Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice. Evidence-Based Complement Altern Med: eCAM. 2012, 2012:461989.
11. Ahmad S.T., Sultana S. Tannic acid mitigates cisplatin-induced nephrotoxicity in mice. Hum Exp Toxicol 2012, 31:145-156.
12. Park K.H., Jeong M.S., Park K.J., Choi Y.W., Seo S.J., Lee M.W. Topical application of Rosa multiflora root extract improves atopic dermatitis-like skin lesions induced by mite antigen in NC/Nga mice. Biol Pharmaceut Bull 2014, 37:178-183.
13. Park K.H., Choi S.E., Choi Y.W., Lee do I., Joo S.S., Jeong M.S., et al. Topical application of two condensed tannins from the root of Rosa multiflora Thunberg for the treatment of atopic dermatitis (AD) in NC/Nga mice. Phytother Res: PTR 2011, 25:1564-1569.
14. Karuppagounder V., Arumugam S., Thandavarayan R.A., Pitchaimani V., Sreedhar R., Afrin R., et al. Resveratrol attenuates HMGB1 signaling and inflammation in house dust mite-induced atopic dermatitis in mice. Int Immunopharmacol 2014, 23:617-623.
15. Arima K., Ohta S., Takagi A., Shiraishi H., Masuoka M., Ontsuka K., et al. Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis. Allerg Int: Off J Jpn Soc Allergol 2015, 64:41-48.
16. Gounder V.K., Arumugam S., Arozal W., Thandavarayan R.A., Pitchaimani V., Harima M., et al. Olmesartan protects against oxidative stress possibly through the Nrf2 signaling pathway and inhibits inflammation in daunorubicin-induced nephrotoxicity in rats. Int Immunopharmacol 2014, 18:282-289.
17. Thandavarayan R.A., Watanabe K., Sari F.R., Ma M., Lakshmanan A.P., Giridharan V.V., et al. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38alpha mitogen-activated protein kinase mice. Free Radical Biol Med 2010, 49:1422-1431.
18. Dahten A., Mergemeier S., Worm M. PPARgamma expression profile and its cytokine driven regulation in atopic dermatitis. Allergy 2007, 62:926-933.
19. Spergel J.M. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allerg Clin North Am 2010, 30:269-280.
20. Lim H.S., Ha H., Lee H., Lee J.K., Lee M.Y., Shin H.K., Morus alba L. Suppresses the development of atopic dermatitis induced by the house dust mite in NC/Nga mice. BMC Complement Alternat Med 2014, 14:139.
21. Han N.R., Moon P.D., Kim H.M., Jeong H.J. Tryptanthrin ameliorates atopic dermatitis through down-regulation of TSLP. Arch Biochem Biophys 2014, 542:14-20.
22. Kim T.H., Kim G.D., Ahn H.J., Cho J.J., Park Y.S., Park C.S. The inhibitory effect of naringenin on atopic dermatitis induced by DNFB in NC/Nga mice. Life Sci 2013, 93:516-524.
23. Majed F., Rashid S., Khan A.Q., Nafees S., Ali N., Ali R., et al. Tannic acid mitigates the DMBA/croton oil-induced skin cancer progression in mice. Mol Cell Biochem 2015, 399:217-228.
24. Zhang H., Zhu S.J., Wang D., Wei Y.J., Hu S.S. Intramyocardial injection of tannic acid attenuates postinfarction remodeling: a novel approach to stabilize the breaking extracellular matrix. J Thoracic Cardiovasc Surg 2009, 137:216-222. 22e1-2.
25. Tikoo K., Bhatt D.K., Gaikwad A.B., Sharma V., Kabra D.G. Differential effects of tannic acid on cisplatin induced nephrotoxicity in rats. FEBS Lett 2007, 581:2027-2035.
26. Tikoo K., Tamta A., Ali I.Y., Gupta J., Gaikwad A.B. Tannic acid prevents azidothymidine (AZT) induced hepatotoxicity and genotoxicity along with change in expression of PARG and histone H3 acetylation. Toxicol Lett 2008, 177:90-96.
27. Liu X., Kim J.K., Li Y., Li J., Liu F., Chen X. Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. J Nutr 2005, 135:165-171.
28. Mori T., Rezai-Zadeh K., Koyama N., Arendash G.W., Yamaguchi H., Kakuda N., et al. Tannic acid is a natural beta-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. J Biol Chem 2012, 287:6912-6927.
29. Jung M.K., Hur D.Y., Song S.B., Park Y., Kim T.S., Bang S.I., et al. Tannic acid and quercetin display a therapeutic effect in atopic dermatitis via suppression of angiogenesis and TARC expression in Nc/Nga mice. J Invest Dermatol 2010, 130:1459-1463.
30. Dahten A., Koch C., Ernst D., Schnoller C., Hartmann S., Worm M. Systemic PPARgamma ligation inhibits allergic immune response in the skin. J Invest Dermatol 2008, 128:2211-2218.
31. Wang G., Liu L., Zhang Y., Han D., Liu J., Xu J., et al. Activation of PPARgamma attenuates LPS-induced acute lung injury by inhibition of HMGB1-RAGE levels. Eur J Pharmacol 2014, 726:27-32.
32. Hwang J.S., Lee W.J., Kang E.S., Ham S.A., Yoo T., Paek K.S., et al. Ligand-activated peroxisome proliferator-activated receptor-delta and -gamma inhibit lipopolysaccharide-primed release of high mobility group box 1 through upregulation of SIRT1. Cell Death Dis 2014, 5:e1432.
33. Orlova V.V., Choi E.Y., Xie C., Chavakis E., Bierhaus A., Ihanus E., et al. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 2007, 26:1129-1139.
34. Gebhardt C., Riehl A., Durchdewald M., Nemeth J., Furstenberger G., Muller-Decker K., et al. RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 2008, 205:275-285.
35. Leibold J.S., Riehl A., Hettinger J., Durben M., Hess J., Angel P. Keratinocyte-specific deletion of the receptor RAGE modulates the kinetics of skin inflammation in vivo. J Invest Dermatol 2013, 133:2400-2406.
36. Mezentsev A.V., Bruskin S.A., Soboleva A.G., Sobolev V.V., Piruzian E.S. Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis. Int J Biomed Sci IJBS 2013, 9:112-122.
37. Matsui T., Yamagishi S., Takeuchi M., Ueda S., Fukami K., Okuda S. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun 2010, 398:326-330.
38. Feng L., Zhu M., Zhang M., Jia X., Cheng X., Ding S., et al. Amelioration of compound 4,4'-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-kappaB pathway. Int Immunopharmacol 2013, 15:206-216.
39. Nakamura H., Aoki M., Tamai K., Oishi M., Ogihara T., Kaneda Y., et al. Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Ther 2002, 9:1221-1229.
40. Tanaka A., Muto S., Jung K., Itai A., Matsuda H. Topical application with a new NF-kappaB inhibitor improves atopic dermatitis in NC/NgaTnd mice. J Invest Dermatol 2007, 127:855-863.
41. Reddy A.T., Lakshmi S.P., Kleinhenz J.M., Sutliff R.L., Hart C.M., Reddy R.C. Endothelial cell peroxisome proliferator-activated receptor gamma reduces endotoxemic pulmonary inflammation and injury. J Immunol 2012, 189:5411-5420.
42. Park M.H., Park J.Y., Lee H.J., Kim D.H., Chung K.W., Park D., et al. The novel PPAR alpha/gamma dual agonist MHY 966 modulates UVB-induced skin inflammation by inhibiting NF-kappaB activity. PLoS ONE 2013, 8:e76820.